Read about Pregnancy Research, Caregiving and more

"FDA Office of Women's Health" <fda@xxxxxxxxxxxxxxxxxxxxxxx> · Thu, 13 Jul 2017 09:38:31 -0500

Title:     Read about Pregnancy Research, Caregiving and more

FDA Office of Women's Health July eUpdate

July 2017

www.fda.gov/womens

Message from the Director
The summer months are an important time to focus on health
and safety. Whether you are helping loved ones find information on their
medicine, searching for the latest research or looking for general summer safety tips, I
encourage you to look to FDA. FDA works to protect women and their families by
approving new treatments and staying at the forefront of research on women�s
health topics. Communicating about product safety issues also remains our
priority. I hope you will continue to use FDA safety and other information to
help make informed decisions for you and your family/ community. In this
update, you will find news on pregnancy
research, a new
treatment for sickle cell disease and opportunities to participate in
public meetings and training webinars.
Marsha
Henderson,
Assistant Commissioner for Women's Health

WOMEN�S HEALTH HIGHLIGHTS

Public Meeting: Task
Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC)
The 21 Century Cures Act established the PRGLAC Task Force to advise the Secretary of HHS regarding gaps in knowledge
and research on safe and effective therapies for pregnant women and lactating
women.

The Task Force will hold a public
meeting on August 21 � 22, 2017, from 8:00am
to 5:30pm at the National Institutes of Health.

Read
the Federal Register Notice
Register
for the Meeting

OWH-Funded Researcher Receives Teratology Society�s 2017 F. Clarke Fraser New Investigator Award
Dr. Evi Struble, of FDA�s Center for Biologics Evaluation
and Research, recently received the Teratology Society�s 2017 F. Clarke Fraser
New Investigator Award in recognition of her OWH-supported study to advance
knowledge of the safety and efficacy of antibody therapeutics used in the
treatment of viral infections during pregnancy. This work has served to demonstrate the suitability of
pregnant guinea pigs as pre-clinical models for these studies. Data from
this study will provide information that can inform dosing decisions during
pregnancy. OWH supports studies such as this one that address the use of
FDA-regulated products during pregnancy.
Learn
more about the Research Award

Read
about other OWH-funded Research related to Pregnancy

Tips for Caregivers
Taking care of family and friends is a normal part of every day for
many women. Caregiving, while rewarding, can be tough at times. FDA has tips to
help women manage the care of loved ones. Read and share tips from our Tips
for Caregivers webpage to help women talk with their family members, other
caregivers and health care providers. Help us spread the word! Share www.fda.gov/caregivertips on your
webpage, social media or in your outreach.

How to Safely Use Nail Care Products
Love manicures and pedicures, or know someone who does? The
cosmetic products you use, along with lamps that dry (or "cure") gel
nail polishes and artificial nails, are regulated by the U.S. Food and Drug
Administration. 
Watch
the video, �5 Ways to Safely Use Nail Drying and Curing�

Read the
Consumer Update

Extras

FDA Approves New Treatment for Sickle Cell Disease
The U.S. Food and Drug Administration�approved Endari (L-glutamine oral powder) for
patients age five years and older with sickle cell disease to reduce severe
complications associated with the blood disorder.

Read
the News Release

FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy
The U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.
Read the Press Announcement

FDA Grand Rounds
Tune in to FDA�s Grand Rounds, webcast live today,
July 13 from 12-1p.m. EDT. Dr. Marc Allard of FDA�s Center for Food Safety and
Nutrition will present, �GenomeTrakr: How a Large Network of Sequencing
Laboratories is Transforming Food Safety and Public Health.�

View
the Meeting Webpage

Meetings

Participate in upcoming FDA Public Meetings.
Biological Advisory Committee Meeting:�Vaccines
and Related Biological Products
July 28, 2017, 8:30 am to 5:00 pm

FDA White Oak Campus , Silver Spring, MD.�

Visit the OWH exhibit booth at these upcoming conferences.
National
Association of Hispanic Nurses
July 18 � 21, 2017, Phoenix, AZ
Association of
American Indian Physicians National Health Conference
July 27 � 30, Shawnee, OK
National Black
Nurses Association
July 30 � August 4, 2017, Las Vegas, Nevada
American
Psychological Association
August 3 � 6, 2017, Washington, DC

Learn
more about OWH staff presentations at national and international
meetings and conferences.

Please share this update with your network, members, constituents, and community.
FDA Office of Women's Health,�owh@xxxxxxx, 301�796�9440
10903 New Hampshire Avenue, WO32�Room 2333, Silver Spring, MD 20993

Subscriber Services: 
Manage Preferences��|��Unsubscribe��|��Help with this service

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery Communications Cloud on behalf of: U.S. Food & Drug Administration (FDA) � 10903 New Hampshire Ave � Silver Spring, MD 20993 � 1-888-INFO-FDA (1-888-463-6332)

Read about Pregnancy Research, Caregiving and more

Message from the Director

WOMEN�S HEALTH HIGHLIGHTS

Public Meeting: Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC)

OWH-Funded Researcher Receives Teratology Society�s 2017 F. Clarke Fraser New Investigator Award

Tips for Caregivers

How to Safely Use Nail Care Products

Extras

FDA Approves New Treatment for Sickle Cell Disease

FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy

FDA Grand Rounds

Meetings

Participate in upcoming FDA Public Meetings.

Visit the OWH exhibit booth at these upcoming conferences.